Tags

Type your tag names separated by a space and hit enter

Surgical management of Skene's gland abscess/infection: a contemporary series.
Int Urogynecol J. 2012 Feb; 23(2):159-64.IU

Abstract

INTRODUCTION AND HYPOTHESIS

We report our experience with surgical excision for treatment of Skene's gland abscess/infection after conservative measures have failed.

METHODS

A retrospective review of patients that underwent surgical excision of Skene's gland abscess/infection by a single surgeon from 06/1995 to 09/2008 was performed. Patients were separated into groups based on indication for procedure. Recurrence rate and success rate were calculated.

RESULTS

The final study group included 34 patients. After initial excision, 88.2% (30/34) of patients had resolution of symptoms. Recurrence of signs and symptoms that prompted further treatment occurred in 30% (9/30). In those that recurred, 88.8% (8/9) of patients had resolution of symptoms after further therapy. Overall success rate in complete resolution of symptoms after all treatment was 85.3%. Only patients to fail were in the urethral pain and recurrent UTI groups.

CONCLUSION

Surgical excision is a safe and effective therapy for the treatment of Skene's gland abscess/infection after conservative measures have failed.

Authors+Show Affiliations

Department of Urology, New York University Langone Medical Center, 150 E 32nd St, New York, NY 10016, USA. uroshah@gmail.comNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

21732101

Citation

Shah, Sagar R., et al. "Surgical Management of Skene's Gland Abscess/infection: a Contemporary Series." International Urogynecology Journal, vol. 23, no. 2, 2012, pp. 159-64.
Shah SR, Biggs GY, Rosenblum N, et al. Surgical management of Skene's gland abscess/infection: a contemporary series. Int Urogynecol J. 2012;23(2):159-64.
Shah, S. R., Biggs, G. Y., Rosenblum, N., & Nitti, V. W. (2012). Surgical management of Skene's gland abscess/infection: a contemporary series. International Urogynecology Journal, 23(2), 159-64. https://doi.org/10.1007/s00192-011-1488-y
Shah SR, et al. Surgical Management of Skene's Gland Abscess/infection: a Contemporary Series. Int Urogynecol J. 2012;23(2):159-64. PubMed PMID: 21732101.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Surgical management of Skene's gland abscess/infection: a contemporary series. AU - Shah,Sagar R, AU - Biggs,Grace Y, AU - Rosenblum,Nirit, AU - Nitti,Victor W, Y1 - 2011/07/06/ PY - 2011/02/06/received PY - 2011/06/14/accepted PY - 2011/7/7/entrez PY - 2011/7/7/pubmed PY - 2012/5/23/medline SP - 159 EP - 64 JF - International urogynecology journal JO - Int Urogynecol J VL - 23 IS - 2 N2 - INTRODUCTION AND HYPOTHESIS: We report our experience with surgical excision for treatment of Skene's gland abscess/infection after conservative measures have failed. METHODS: A retrospective review of patients that underwent surgical excision of Skene's gland abscess/infection by a single surgeon from 06/1995 to 09/2008 was performed. Patients were separated into groups based on indication for procedure. Recurrence rate and success rate were calculated. RESULTS: The final study group included 34 patients. After initial excision, 88.2% (30/34) of patients had resolution of symptoms. Recurrence of signs and symptoms that prompted further treatment occurred in 30% (9/30). In those that recurred, 88.8% (8/9) of patients had resolution of symptoms after further therapy. Overall success rate in complete resolution of symptoms after all treatment was 85.3%. Only patients to fail were in the urethral pain and recurrent UTI groups. CONCLUSION: Surgical excision is a safe and effective therapy for the treatment of Skene's gland abscess/infection after conservative measures have failed. SN - 1433-3023 UR - https://www.unboundmedicine.com/medline/citation/21732101/Surgical_management_of_Skene's_gland_abscess/infection:_a_contemporary_series_ L2 - https://dx.doi.org/10.1007/s00192-011-1488-y DB - PRIME DP - Unbound Medicine ER -